Aqr Capital Management LLC Century Therapeutics, Inc. Transaction History
Aqr Capital Management LLC
- $95.2 Billion
- Q1 2025
A detailed history of Aqr Capital Management LLC transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 111,079 shares of IPSC stock, worth $61,093. This represents 0.0% of its overall portfolio holdings.
Number of Shares
111,079
Previous 24,204
358.93%
Holding current value
$61,093
Previous $24,000
120.83%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IPSC
# of Institutions
69Shares Held
26.7MCall Options Held
12.1KPut Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$2.98 Million0.87% of portfolio
-
Casdin Capital, LLC New York, NY3.21MShares$1.77 Million0.18% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$1.59 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY2.5MShares$1.37 Million0.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$1.31 Million0.0% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $32.4M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...